AMANDA BROWN: Open Payments
NPI 1538634100 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,044 in 44 payments from 10 companies in 2025. Trend: 2023 $108 · 2024 $141 · 2025 $1,044
Food & beverage: $949Education: $95
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $284 |
| ABBVIE INC. | 16 | $270 |
| GENZYME CORPORATION | 3 | $171 |
| Janssen Biotech, Inc. | 2 | $117 |
| Amgen Inc. | 3 | $57 |
| PFIZER INC. | 3 | $45 |
| Organon LLC | 2 | $42 |
| LEO Pharma Inc. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Galderma Laboratories, L.P. | 1 | $16 |
Products named: SKYRIZI, DUPIXENT, COSENTYX, TREMFYA, RINVOQ, OTEZLA, CIBINQO, ANZUPGO.
Industry payments across MS — which companies pay providers there.
